RENAISSANCE TECHNOLOGIES LLC

Position in VERA — Vera Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in VERA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,994,546

-$6,402,633 QoQ

Shares Held

279,528

-38.9% QoQ

Ownership

0.388%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#46

of 217 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. VERA ranks #46 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,994,546	279,528	-38.9%	Shares	Sole	2026-08-13
2026-03-31	$18,397,179	457,300	+136.5%	Shares	Sole	2026-05-14
2025-12-31	$9,793,776	193,400	+376.4%	Shares	Sole	2026-02-12
2025-03-31	$975,212	40,600	+13.7%	Shares	Sole	2025-05-14
2024-12-31	$1,509,753	35,700	-75.8%	Shares	Sole	2025-02-13
2024-06-30	$5,347,404	147,800	+28.5%	Shares	Sole	2024-08-09
2024-03-31	$4,958,800	115,000	+31.9%	Shares	Sole	2024-05-13
2023-09-30	$1,195,512	87,200	-50.1%	Shares	Sole	2023-11-14
2023-03-31	$1,356,448	174,800	+602.0%	Shares	Sole	2023-05-12
2022-12-31	$481,815	24,900	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.